Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1) [Phase 2]
A Phase 2 study of DS-8201a in metastatic breast cancer previously treated with trastuzumab emtansine (T-DM1) was terminated. Results were p…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After? [Phase 2]
Phase 2 study evaluating the sequence of anthracycline and taxane in neoadjuvant therapy for breast cancer; results not yet reported.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer [Phase 2]
Phase 2 trial evaluating a vaccine therapy in breast cancer patients receiving trastuzumab for HER2-positive disease; study completed.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Single Dose Partial Breast Radiotherapy [Phase 1]
Phase 1 clinical trial update for single-dose partial breast radiotherapy in breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer [NA]
A completed clinical trial evaluated topical keratin for treating radiation dermatitis in breast cancer patients. The results have been post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-11Clinical Trial Update: F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy [NA]
Clinical trial assessing F-18 FES PET/CT to measure hormone expression in estrogen receptor–positive breast cancer during endocrine-targeted…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Exergaming Intervention and Breast Cancer Biomarkers in Black Women [Phase 2]
Phase 2 clinical trial evaluating an exergaming intervention and its impact on breast cancer biomarkers in Black women; study completed.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating vaccine therapy in combination with Rintatolimod and/or Sargramostim for HER2-positive breas…
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery [Phase 3]
Phase 3 trial evaluating anastrozole, letrozole, or exemestane with or without tamoxifen in postmenopausal women with hormone-responsive bre…
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Effects of High Dose Calcitriol in Breast Cancer Patients [Phase 2]
Phase 2 trial evaluating high-dose calcitriol in breast cancer patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Pyrotinib in Breast Cancer Patients With Poor Response to the Neoadjuvant Treatment of Trastuzumab and Pertuzumab [Phase 2]
Phase 2 clinical trial update investigating pyrotinib in breast cancer patients with poor response to neoadjuvant trastuzumab and pertuzumab…
-
FDA approval · 2020-02-07FDA Approved: FULVESTRANT — Original Application (Sagent Pharmaceuticals)
FDA approved an original application for a generic fulvestrant product from Sagent Pharmaceuticals for breast cancer treatment.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer [Phase 2]
Phase 2 trial investigating rosuvastatin to lower circulating tissue factor–bearing microparticles in metastatic breast cancer has completed…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer [Phase 2]
A Phase 2 trial comparing capecitabine plus pyrotinib to capecitabine plus trastuzumab and pertuzumab for first-line treatment of HER2-posit…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer [Phase 2]
Phase 2 trial comparing fulvestrant plus placebo versus fulvestrant plus palbociclib as first-line therapy for postmenopausal HR-positive ad…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Immunogenicity and Safety of DCs in Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial assessing immunogenicity and safety of dendritic cells in breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: Serratus Plane Block vs Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Unilateral Breast Surgery [Phase 4]
Phase 4 trial comparing serratus plane block to erector spinae plane block for postoperative analgesia after unilateral breast surgery.
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer [Phase 2]
Phase 2 pharmacodynamic trial update in newly diagnosed operable breast cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-28Clinical Trial Update: Prone Breast Irradiation for Pendulous Breasts [NA]
Clinical trial update for prone breast irradiation in pendulous breasts with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors [Phase 2]
Phase 2 trial evaluating low-dose tamoxifen citrate to reduce breast cancer risk in radiation-induced cancer survivors. Results were posted …
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial investigating letrozole in combination with imatinib mesylate for postmenopausal women with estrogen receptor–positiv…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates [Phase 1, Phase 2]
A neoadjuvant trial evaluating paclitaxel alone versus BIBF 1120 priming followed by BIBF 1120 plus paclitaxel in early HER-2 negative breas…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating sapanisertib with exemestane or fulvestrant in postmenopausal ER+/HER2- metastatic breast cancer completed with pos…
-
FDA approval · 2020-01-24FDA Approved: TRAZIMERA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved Pfizer's supplemental Biologics License Application for TRAZIMERA (trastuzumab-qyyP), a biosimilar to trastuzumab.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer [Phase 1, Phase 2]
A phase 1/2 trial assessing pegylated liposomal doxorubicin plus albumin-bound paclitaxel and trastuzumab in HER-2 positive breast cancer is…